New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
12:21 EDTURS, HLIT, MYL, AAPL, ACM, RVBD, C, ABTOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday to start the week after Citigroup's (C) better than expected headline results appeared to renew investor optimism over the earnings season. Also, a number of additional M&A deals were reported over the weekend and this morning. Since its initial move higher the market has moved in a very narrow range, but the early gains are still enough to put the major averages on track for their best daily performance since late May. ECONOMIC EVENTS: In the U.S., no major economic data was released this morning. COMPANY NEWS: Shares of Citigroup (C), the second major U.S. bank to report on its second quarter results, advanced 3% after its headline earnings and revenue beat expectations. Also, the bank announced that it has reached a $7B settlement that resolves actual and potential civil claims by the Department of Justice, several state attorneys general and the Federal Deposit Insurance Corporation relating to RMBS and collateralized debt obligations issued, structured or underwritten by Citi between 2003 and 2008... Mylan (MYL) struck a deal to buy Abbott's (ABT) non-U.S. developed markets specialty and branded generics business in an all-stock transaction valued at about $5.3B. Under the terms of the deal, Abbott will carve out the assets and transfer them to a new public company organized in the Netherlands. Mylan will then merge with that company to become a new public company, called Mylan N.V., allowing it certain tax advantages. Abbott will receive 105M shares of the combined company, meaning it will hold an approximate 21% stake in Mylan following the deal. Shares of both companies advanced after the deal announcement, with Abbott gaining 1% and Mylan rising nearly 3%. MAJOR MOVERS: Shares of Apple (AAPL) rose 1.5% after Barclays upgraded its stock to Overweight and raised its price target for the shares to $110 from $95, citing channel checks that indicate near-term upside to consensus estimates and strong new products into 2015. The firm also said it believes troubles at Samsung are creating an opportunity for Apple to regain market share. Meanwhile, Morgan Stanley reported that its survey results suggests June quarter iPhone demand upside and the firm raised its iPhone unit estimate and its EPS estimate for the coming quarter above the consensus forecasts. Among the notable gainers with merger news was URS (URS), which rose about 11% after it announced this weekend that it agreed to be acquired by AECOM Technology (ACM) for a combination of cash and stock valued at approximately $4B, or $56.31 per URS share. Shares of the buyer also rose 7.5% after the announcement. Among the noteworthy losers was Harmonic (HLIT), which plunged 10.5% after the company's second and third quarter outlooks fell significantly short of analysts' consensus estimates. Also lower following its own profit warning was Riverbed (RVBD), which fell 5.5% after the company cut its second quarter adjusted EPS and revenue outlook. Afterward, activist investor Elliot Management reaffirmed its prior $21 per share bid for the company and urged the company's board to "immediately" retain an advisor and announce a review of strategic alternatives, including a sale. INDEXES: Near midday, the Dow was up 129.89, or 0.77%, to 17,073.70, the Nasdaq was up 31.62, or 0.72%, to 4,447.11, and the S&P 500 was up 11.13, or 0.57%, to 1,978.70.
News For C;AAPL;URS;RVBD;MYL;ABT;ACM;HLIT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
July 21, 2015
06:23 EDTAAPLApple's iPhone 6s will cut 16GB version, M.I.C. Gadget reports
Apple's (AAPL) new iPhone 6s and 6s Plus will not come with a 16GB edition yet will have a 32GB edition with more capacity, M.I.C. Gadget reports, citing "some Foxconn (FXCNY) insiders." Reference Link
06:19 EDTAAPLSilicon Valley giants side with Samsung in battle with Apple, InsideSources says
Subscribe for More Information
05:34 EDTAAPLPayPal initiated with an Underweight at Piper Jaffray
Piper Jaffray analyst Gene Munster started shares of PayPal (PYPL) with an Underweight rating saying increased competition could pressure the stock's multiple over the next 6-24 months. Underweight is Piper's equivalent of a sell rating. Google's (GOOG) Android Pay and Apple's (AAPL) Apple Pay will give consumers a "real alternative to PayPal" for the first time, Munster tells investors in a research note. In addition, interest in payments from Amazon.com (AMZN) and Facebook (FB) bring potential for more digital wallet offerings, the analyst notes. Munster set a $30 price target for PayPal, which began trading yesterday following a spinoff from parent company eBay (EBAY). Shares of the online payment system closed Monday up $2.08 to $40.47.
July 20, 2015
19:00 EDTAAPLApple hires auto industry executive, WSJ says
Apple has hired Doug Betts, former global head of quality at Chrysler Group, reports the Wall Street Journal, citing Betts' LinkedIn profile. The report notes that the move could mean Apple's rumored electric car development "may be gaining ground." Reference Link
16:01 EDTC, AAPLOptions Update; July 20, 2015
Subscribe for More Information
13:37 EDTAAPLApple July weekly volatility increases into Q3 and outlook
Apple July weekly call option implied volatility is at 56, August is at 31, October is at 26; compared to its 52-week range of 15 to 36, suggesting large near term price movement into the expected release of Q3 results on July 21.
13:28 EDTAAPLSamsung most popular smartphone maker in Q2, TrendForce says
Samsung (SSNLF) was the most popular smartphone maker in the second quarter, even though the smartphone market has started to slow down, according to data from research firm TrendForce. Smartphone shipments will grow 8.2% year over year in 2015, though that's down from the previously anticipated growth rate of 11.6%, the report says. Samsung has led in smartphone shipments with a second-quarter growth of 26.8%. However, Galaxy S6 and S6 Edge's annual shipment forecast has been marked down repeatedly. TrendForce has also revised Samsung's annual smartphone shipments downwards to 45M units this year. As Chinese vendors are taking more shares of the low- to mid-range product market, Samsung's ability to reverse its fortune may hinge on the success of its Galaxy Note 5. If this device is able to attract consumers with upgraded specs and new features, then Samsung will avoid the high possibility of negative shipment growth for this year. Apple (AAPL) rode on the popularity of iPhone 6 and iPhone 6 Plus in this year's first half and achieved a remarkably strong shipment result in the off-peak season. The next-generation iPhone due to be launched this year offers no major changes in appearance, but Apple has given the device a new A9 processor and upgraded its memory to 2GB LPDDR4 for the first time. These improvements along with the Force Touch module and a camera featuring a possible resolution of 12MP will give the next iPhone a huge boost. Thus, TrendForce's iPhone shipment forecast for this year continues to be very positive with a high growth of 15% upwards. Lenovo (LNVGY) has fallen to No. 6 in the global shipment ranking and is expected to see a 20%-30% decline in this year's shipments. Lenovo's market share did not double as anticipated after its takeover of Motorola in 2014. Moreover, Lenovo did not have a well-defined product positioning strategy and the brand faced strong competition from challengers offering lower-priced smartphone models.
13:03 EDTCFed proposes final rule on capital surcharges for largest U.S. banks
Subscribe for More Information
12:40 EDTAAPLEarnings Watch: IBM up 4% since last quarterly report
Subscribe for More Information
10:07 EDTAAPLApple rallies ahead of earnings
Shares are up over 1.3% to $131.41 at time of writing. At that price next resistance is at $134.54, the life high. Support is at $130.50.
09:34 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:02 EDTABTAbbott receives FDA approval and launches iDesign Advanced WaveScan system
Subscribe for More Information
08:38 EDTMYL, ABTAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:33 EDTMYL, ABTInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTMYL, ABTZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
06:48 EDTAAPLApple in talks to create free streaming TV channel, NY Post reports
Subscribe for More Information
06:39 EDTAAPLNew iPods won't run Apple Music to prevent piracy, 9to5Mac reports
Subscribe for More Information
06:31 EDTAAPLAnalysts down on Apple Watch sales, AFP reports
Certain analysts have said that Apple's new smartwatch is not a mainstream hit due its disappointingly low sales figures, AFP reports. A study from Slice Intelligence suggests that Apple Watch orders have decreased 90% since the week the device made its debut, the report says. In response, BMO Capital Markets said it told investors that they were "disappointed" and reduced their estimate for Apple Watch sales in the upcoming year, the report adds. Richard Windsor at Edison Investment Research said that even if Slice is off the mark about the plunge in Apple Watch orders, it was evident that the wearable has sold way less than even conservative expectations, AFP says. Reference Link
06:22 EDTAAPLApple July weekly volatility elevated into Q3 and outlook
Subscribe for More Information
05:57 EDTAAPLApple iPhone momentum to continue in June quarter, says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use